Clene Financial Statements From 2010 to 2025

CLNN Stock  USD 3.54  0.05  1.43%   
Clene's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Clene's valuation are provided below:
Gross Profit
276 K
Market Capitalization
31.3 M
Enterprise Value Revenue
121.3108
Revenue
350 K
Earnings Share
(4.03)
We have found one hundred twenty available fundamental signals for Clene Inc, which can be analyzed and compared to other ratios and to its rivals. Self-guided Investors are advised to validate Clene's prevailing fundamentals against the trend between 2010 and 2025 to make sure the company can sustain itself down the road.

Clene Total Revenue

439,634

Check Clene financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Clene's main balance sheet or income statement drivers, such as Other Operating Expenses of 27.5 M, Total Operating Expenses of 27.4 M or Depreciation And Amortization of 1.3 M, as well as many indicators such as Price To Sales Ratio of 103, Dividend Yield of 0.0 or Days Sales Outstanding of 396. Clene financial statements analysis is a perfect complement when working with Clene Valuation or Volatility modules.
  
Build AI portfolio with Clene Stock
Check out the analysis of Clene Correlation against competitors.

Clene Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding4.4 MM3.6 M
Slightly volatile
Total Assets36.3 M27.3 M45.7 M
Pretty Stable
Short and Long Term Debt Total18.7 M20.8 M10.2 M
Slightly volatile
Other Current Liabilities4.4 M4.1 M2.6 M
Slightly volatile
Total Current Liabilities11.3 M10.3 M5.3 M
Slightly volatile
Other Liabilities2.2 M2.3 M8.8 M
Pretty Stable
Property Plant And Equipment Net10 M11.1 M6.8 M
Slightly volatile
Accounts Payable1.7 M1.2 M1.3 M
Slightly volatile
Cash11.5 M12.2 M12.2 M
Slightly volatile
Non Current Assets Total12.1 M11.2 M30.5 M
Slightly volatile
Cash And Short Term Investments11.5 M12.2 M12.9 M
Slightly volatile
Liabilities And Stockholders Equity36.3 M27.3 M45.7 M
Pretty Stable
Non Current Liabilities Total32.9 M25.9 M41 M
Slightly volatile
Other Current Assets2.6 M3.5 M1.2 M
Slightly volatile
Total Liabilities41.1 M36.2 M46.1 M
Very volatile
Total Current Assets15.3 M16.2 M14.6 M
Slightly volatile
Accumulated Other Comprehensive Income67.5 K71 K86.5 K
Slightly volatile
Short Term Debt1.2 M1.3 M3.8 M
Pretty Stable
Common Stock95010002.4 K
Slightly volatile
Property Plant Equipment18.4 M17.5 M7.7 M
Slightly volatile
Long Term Debt10.8 M15.4 M4.7 M
Slightly volatile
Net Receivables371.4 K391 K757 K
Pretty Stable
Common Stock Total Equity5.8 K8.1 K3.7 K
Slightly volatile
Capital Lease Obligations4.8 M5.1 M3.2 M
Slightly volatile
Inventory54.4 K68 K44.6 K
Slightly volatile
Property Plant And Equipment Gross13.5 M19 M8.5 M
Slightly volatile
Capital Stock95010003.4 K
Slightly volatile
Net Working Capital5.6 M5.9 M12 M
Slightly volatile
Long Term Debt TotalM16.7 M5.7 M
Slightly volatile
Capital Surpluse192.7 M225.7 M167.2 M
Slightly volatile
Deferred Long Term Liabilities21.9 M20.8 M6.2 M
Slightly volatile
Non Current Liabilities Other72.7 K76.5 K36.7 M
Slightly volatile
Other Assets46.4 K52.2 K56.9 K
Slightly volatile
Short and Long Term Debt341.1 K359 K6.5 M
Very volatile

Clene Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses27.5 M33.4 M14.2 M
Slightly volatile
Total Operating Expenses27.4 M33.4 M14.2 M
Slightly volatile
Depreciation And Amortization1.3 M1.6 M944.4 K
Slightly volatile
Selling General Administrative12.2 M13.3 M6.9 M
Slightly volatile
Selling And Marketing Expenses1.1 MM1.7 M
Slightly volatile
Research Development21.8 M20.1 M13.3 M
Slightly volatile
Cost Of Revenue66.5 K70 K602.3 K
Slightly volatile
Reconciled Depreciation1.3 M1.6 M996 K
Slightly volatile
Non Operating Income Net Other23.7 M25.1 M9.9 M
Slightly volatile
Interest Income909 K865 K380.5 K
Slightly volatile

Clene Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation6.2 MMM
Slightly volatile
Depreciation1.2 M1.6 M900.6 K
Slightly volatile
Capital Expenditures14.2 K15 K895 K
Very volatile
End Period Cash Flow11.6 M12.2 M12.3 M
Slightly volatile
Change To Netincome5.5 M9.6 M4.3 M
Slightly volatile
Issuance Of Capital Stock8.8 M9.2 M13 M
Slightly volatile
Sale Purchase Of Stock13.5 M10.6 M24.9 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1031082.2 K
Slightly volatile
Days Sales Outstanding3964172.8 K
Slightly volatile
Stock Based Compensation To Revenue12.1623.25447.8198
Slightly volatile
Capex To Depreciation0.00870.00911.0943
Very volatile
EV To Sales127133K
Slightly volatile
Inventory Turnover0.981.029420.9189
Slightly volatile
Days Of Inventory On Hand404355170
Slightly volatile
Payables Turnover0.05360.05650.6582
Slightly volatile
Sales General And Administrative To Revenue23.6538.909426.3428
Slightly volatile
Research And Ddevelopement To Revenue61.658.649167.4786
Slightly volatile
Capex To Revenue0.04170.04392.1279
Very volatile
Cash Per Share1.661.74793.4486
Slightly volatile
Days Payables Outstanding8.3 K6.5 K4.6 K
Slightly volatile
Income Quality0.510.54130.9365
Pretty Stable
Current Ratio1.491.573.4603
Pretty Stable
Receivables Turnover0.70.87470.3787
Slightly volatile
Capex Per Share0.0020.00220.2783
Very volatile
Revenue Per Share0.04670.04920.078
Slightly volatile
Interest Debt Per Share3.753.58162.8035
Slightly volatile
Debt To Assets0.80.76240.2591
Slightly volatile
Operating Cycle1.5 K772611
Slightly volatile
Days Of Payables Outstanding8.3 K6.5 K4.6 K
Slightly volatile
Quick Ratio1.491.56343.4578
Pretty Stable
Cash Ratio1.121.18113.1466
Pretty Stable
Days Of Inventory Outstanding404355170
Slightly volatile
Days Of Sales Outstanding3964172.8 K
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.721.00073.1188
Slightly volatile
Fixed Asset Turnover0.05180.03070.0425
Pretty Stable
Debt Ratio0.80.76240.2591
Slightly volatile
Price Sales Ratio1031082.2 K
Slightly volatile
Asset Turnover0.0080.01250.0055
Slightly volatile
Gross Profit Margin0.620.79530.7065
Slightly volatile

Clene Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap27.2 M36.9 M31.2 M
Very volatile
Enterprise Value32 M45.6 M35 M
Pretty Stable

Clene Fundamental Market Drivers

Cash And Short Term Investments12.2 M

Clene Upcoming Events

11th of March 2024
Upcoming Quarterly Report
View
10th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
11th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Clene Financial Statements

Clene investors utilize fundamental indicators, such as revenue or net income, to predict how Clene Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue 1.15  1.21 
Total Revenue342 K439.6 K
Cost Of Revenue70 K66.5 K
Stock Based Compensation To Revenue 23.25  12.16 
Sales General And Administrative To Revenue 38.91  23.65 
Research And Ddevelopement To Revenue 58.65  61.60 
Capex To Revenue 0.04  0.04 
Revenue Per Share 0.05  0.05 
Ebit Per Revenue(96.76)(101.60)

Pair Trading with Clene

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Clene position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clene will appreciate offsetting losses from the drop in the long position's value.

Moving together with Clene Stock

  0.61A Agilent Technologies Earnings Call TodayPairCorr

Moving against Clene Stock

  0.64DRMA Dermata TherapeuticsPairCorr
  0.63VRAX Virax Biolabs GroupPairCorr
  0.58CDIOW Cardio DiagnosticsPairCorr
  0.54DRUG Bright Minds BiosciencesPairCorr
  0.54DYAI Dyadic International Earnings Call This WeekPairCorr
The ability to find closely correlated positions to Clene could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Clene when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Clene - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Clene Inc to buy it.
The correlation of Clene is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Clene moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Clene Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Clene can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Clene Inc is a strong investment it is important to analyze Clene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Clene's future performance. For an informed investment choice regarding Clene Stock, refer to the following important reports:
Check out the analysis of Clene Correlation against competitors.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clene. If investors know Clene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.614
Earnings Share
(4.03)
Revenue Per Share
0.046
Quarterly Revenue Growth
0.11
Return On Assets
(0.50)
The market value of Clene Inc is measured differently than its book value, which is the value of Clene that is recorded on the company's balance sheet. Investors also form their own opinion of Clene's value that differs from its market value or its book value, called intrinsic value, which is Clene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clene's market value can be influenced by many factors that don't directly affect Clene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.